• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lifeward Ltd. - Ordinary Shares (NQ:LFWD)

6.480 -0.120 (-1.82%)
Streaming Delayed Price Updated: 1:01 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Lifeward Ltd. - Ordinary Shares

< Previous 1 2 3 Next >
News headline image
Lifeward Reports First Quarter 2026 Financial Results
Today 8:00 EDT
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026
May 11, 2026
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton
May 04, 2026
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Successfully Closes on Strategic Partnership with Oramed
March 25, 2026
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
March 18, 2026
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
March 13, 2026
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
March 11, 2026
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
March 10, 2026
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
March 02, 2026
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
February 25, 2026
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Announces Reverse Share Split
February 20, 2026
Reverse split initiated as Lifeward enters strategic partnership agreement and repositions as MedTech innovation company 
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
February 17, 2026
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
January 13, 2026
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Appoints Bob Marshall as Chairman of the Board
December 19, 2025
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
December 17, 2025
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
December 03, 2025
From Lifeward Ltd.
Via GlobeNewswire
News headline image
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton
November 17, 2025
Approval marks continued progress in expanding reimbursement pathways and accelerating access to advanced personal exoskeleton technology for individuals with spinal cord injury. 
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Ltd. Reports Third Quarter 2025 Financial Results
November 14, 2025
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward to Report Third Quarter Financial Results on November 14, 2025
November 10, 2025
From Lifeward Ltd.
Via GlobeNewswire
News headline image
First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
September 09, 2025
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
September 08, 2025
Seventh generation of industry-leading ReWalk Exoskeleton is now cleared for commercial launch in the European Union 
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Ltd. Reports Second Quarter 2025 Financial Results
August 14, 2025
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership
August 13, 2025
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward to Report Second Quarter Financial Results on August 14, 2025
August 07, 2025
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
August 04, 2025
Expansion adds additional AlterG dealer coverage to 6 countries throughout the Gulf Cooperation Council region 
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Announces Closing of $2.6 Million Public Offering
June 26, 2025
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Announces Pricing of $2.6 Million Public Offering
June 25, 2025
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary
June 24, 2025
Decision at the highest levels of appeal in the Medicare process establishes medical necessity of the ReWalk Exoskeleton for enabling paralyzed individuals to stand and walk in everyday environments. 
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Names Mark Grant as New CEO
May 19, 2025
Industry veteran brings 30 years of commercial leadership experience 
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward to Present at Sidoti Virtual Investor Conference on May 21
May 19, 2025
From Lifeward Ltd.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap